AC FORUM 2025 | 18th National Conference

Home
Conference Program

Conference Program

Become a Center of Excellence - Join us on Stage in April!
All 2025 new and renewed ACE sites will be recognized at the National Conference. We have reserved time on the morning of conference Day 2 to recognize and congratulate all ACE sites. As a special acknowledgment, we will invite all sites that pass the ACE Assessment from January 1 - March 31, 2025, up on stage to receive their ACE Certificate.

Please note that all times are U.S. Eastern Time.

If you've already created a free AC Forum account and would like to register for the National Conference, log in to your Member Dashboard and click on "Attendee Registration" under the "National Conference" tab.

Thu - Apr 03

Fri - Apr 04

Sat - Apr 05

View Summary Only

THURSDAY, APRIL 3, 2025

10:00 - 11:55 AM

PLENARY SESSION

SESSION #1: LET'S GET GOING
Chair/Organizer: Ronni Nemeth, Carlee O'Connor
Arlington Ballroom, Salons 1-3

10:00

State of the AC Forum
Allison Burnett

10:15

Obtaining Administrative Support for Anticoagulation Stewardship
Allison Burnett

10:40

Inspiring Legislative Change - Anticoagulation Stewardship Advocacy
Leslie Lake

10:50

Top Papers You Need to Know
Tracy Minichiello San Francisco VA Medical Center/University of California San Francisco

Mike Streiff Johns Hopkins University

11:35

Q&A panel

11:45 - 1:25 PM

SATELLITE WORKSHOP

SITUATION ROOM: CASE-BASED UNBRANDED/NON-PROMOTIONAL SMALL GROUP DISCUSSION (SPONSORED BY BRISTOL MYERS SQUIBB - PFIZER ALLIANCE)
Grand Ballroom, Salons FGH

Doors open at 11:45, program starts at 12:00

Lunch will be provided.

The Situation Room is a new platform for peer-to-peer learning and sharing where you can share your clinical experience and insights with your peers based on a simple clinical scenario without a speaker/lecturer to maximize natural interactive discussion in a small group.

Each table is facilitated by a Pfizer Medical Director (FMD) for more diverse discussions. All FMD's are credentialed professionals with extensive experience in the areas of cardiovascular disease states.

Features of a Situation Room:

No speaker presentation/lecture

Simple case scenario

Goal is not to solve the case but discuss how to approach

Interactive engaging discussion in a small group setting

Small groups of 7-8 HCP participants with one FMD facilitator

THIS SESSION IS NOW FULL! Still interested? Please stop by the meeting room at the time of the event in case walk-in space becomes available.

1:25 - 3:15 PM

PLENARY SESSION

SESSION #2: ENTERING THE GRAY ZONE
Chair/Organizer: Tracy Minichiello, Stephan Moll
Arlington Ballroom, Salons 1-3

1:25

Thrombophilia - To Test, or Not to Test?
Jean Connors Brigham and Women's Hospital

Damon Houghton Mayo Clinic

1:55

APS Challenges
Ana Casanegra Mayo Clinic

Shruti Chaturvedi Johns Hopkins University

2:25

DOAC Reversal
Gabe Fontaine Intermountain Health

Deborah Siegal University of Ottawa and Ottawa Hospital Research Institute

2:55

Q&A panel

3:15 - 3:45 PM

BREAK

BREAK
Arlington Ballroom, Salons 4-6

3:45 - 5:20 PM

PLENARY SESSION

SESSION #3: CHECK YOURSELF BEFORE YOU WRECK YOURSELF
Chair/Organizer: Scott Kaatz, Laurie Sardo
Arlington Ballroom, Salons 1-3

3:45

Coagulation Testing - Who? What? When?
Karina Meijer University Medical Center Groningen

4:10

Yay or Nay to Anticoagulate?
Snehal Bhatt Massachusetts College of Pharmacy and Health Sciences

4:35

Common Mistakes to Avoid
Arthur Allen VA Salt Lake City Health Care System

5:00

Q&A Panel

5:30 - 6:30 PM

POSTER SESSION

WELCOME RECEPTION & POSTER PRESENTATIONS (click to view) (click to close)
Arlington Ballroom, Salons 4-6

ANTICOAGULATION CLINIC MODELS OF CARE

A1

Utilization of a Direct Oral Anticoagulant (DOAC) Population Management Tool (PMT): Standardizing Assessment of Liver Flags
Christina M Bookwalter, Michelle Anderson, Heather Poepping, Julie Spenner Minneapolis VA Health Care System, Minneapolis, MN, USA

A2

Comparison of anticoagulation control and outcomes between usual medical care and pharmacist-led anticoagulation service in ambulatory patients taking warfarin at tertiary hospital in Ethiopia: a quasi-experimental study
Tamrat Assefa Tadesse¹, Amha Gebremedhin², Dejuma Yadeta², Legese Chelkeba¹, Teferi Gedif¹ ¹School of Pharmacy, CHS, Addis Ababa University, Addis Ababa, Ethiopia.²School of Medicine, CHS, Addis Ababa University, Addis Ababa, Ethiopia

A4

Automation, Expansion and Optimization of an Emergency Department Transition of Care Program for Outpatient Management of Acute Venous Thromboembolic Disease: Experience with our Facilitating Anticoagulation for Safer Transitions (FAST) Enterprise Health System Program.
Lynda J Thomson¹, Menaka Suri¹, Geno J Merli¹, Huelena Nguyen² ¹Jefferson Vascular Center, Thomas Jefferson University Hospital, Philadelphia, PA, USA.²Jefferson College of Pharmacy, Philadelphia, PA, USA

A5

Implementing & Integrating a Virtual Nurse-Led Anticoagulation Clinic Care Team
Kristin D.F. Negley^{1, 2}, Gina M. Foster^{1, 2}, Jeffrey P. Timm^{1, 2}, Angela Mattson^{1, 2} ¹Mayo Clinic, Rochester, MN, USA.²Mayo Clinic Health System, Southeast, MN, USA

A6

Improving the Perioperative Process for Patients Panaged by a Pharmacist-Pun Anticoagulation Clinic
Sanela Lekic, Katie Kish, Kayla Woicehovich, Amita Pandya, Brandy Ungham, Nicole Bonnallie, Angela Sanders Cleveland Clinic Foundation, Cleveland, OH, USA

A7

Continued Assessment of a Direct Oral Anticoagulant (DOAC) Dashboard
Nghi Ha, Nhan Hoang, Liza Renner, Erin Mouland, Michael Lanham, Geoff Barnes Michigan Medicine, Ann Arbor, MI, USA

A8

Implementation of a Warfarin Patient Self-Management Program in Patients on Chronic Warfarin Therapy
Allison Dery, Ashley Varela-Martinez, Charlene Nash, Darla Althizer Sentara Medical Group - Sentara Health, Norfolk, VA, USA

A9

Implementation of a Centralized Direct Oral Anticoagulant Surveillance Program
Sandra Hedin, Melissa Fontana, Briana Ballister Centralized Anticoagulation Services Hub, VA Great Lakes Health Care System, Westchester, IL, USA

ANTICOAGULATION STEWARDSHIP

B1

The Impact of a VA DOAC Population Management Tool Flag for Concurrent Antiplatelets
Allison/B Riendeau, Christi/A Albert William S Middleton Memorial Veterans Hospital, Madison, WI, USA

B2

Safety Huddles in Anticoagulation Clinic Practice
Abbie M Helmrick, Christina M Bookwalter VA Medical Center, Minneapolis, MN, USA

B3

Adherence to Direct Oral Anticoagulants among U.S. Veterans with Atrial Fibrillation in the Era of the Veteran Health Administration DOAC Population Management Tool
Arthur Allen¹, Shardool Patel², Brian Sauer², Bishoy Ragheb³ ¹VA Salt Lake City Health Care System, Salt Lake City, UT, USA.²VA Salt Lake City Health Care System and The University of Utah, Salt Lake City, UT, USA.³VA Eastern Colorado Health Care System, Aurora, CO, USA

B4

Population Management Tools Facilitate Anticoagulation Stewardship within Veterans Health Administration
Arthur Allen¹, Briana Ballister², Bishoy Ragheb³, Geoffrey Barnes⁴ ¹VA Salt Lake City Health Care System, Salt Lake City, UT, USA.²Center for Medication Safety, VA Pharmacy Benefits Management Services, Hines, IL, USA.³VA Eastern Colorado Health Care System, Aurora, CO, USA.⁴University of Michigan, Ann Arbor, MI, USA

B6

Risk Mitigation of Gastrointestinal Bleeding in Patients Co-Prescribed Antiplatelets with Oral Anticoagulants: VISN 8 Anticoagulation Stewardship Proton Pump Inhibitor Initiative
David Parra^{1, 2}, Jeffery L Kibert II¹, Natalie R Ciccone³, Litzalee Camacho-Vega⁴, Joseph Capriola⁵, Jennifer L Crowley⁴, Joseph J Fierro⁶, Alida Marrero-Hernandez⁴, Maria J Irias⁷, Robert D Stewart⁸, Jaclyn Stoppi⁹, Elyse C Wilson⁸, Laura K Vinieratos⁸, for the VISN 8 Pharmacy Anticoagulation Workgroup¹ ¹Veterans Health Administration VISN 8 Pharmacy Benefits Management, Bay Pines, FL, USA.²College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.³Orlando Veterans Affairs Health Care System, Orlando, FL, USA.⁴Caribbean Veterans Affairs Health Care System, San Juan, PR, USA.⁵North Florida South Georgia Veterans Health Care System, Gainesville, FL, USA.⁶Tampa Bay Veterans Affairs Health Care System, Tampa, FL, USA.⁷Miami Veterans Affairs Health Care System, Miami, FL, USA.⁸Bay Pines Veterans Affairs Health Care System, Bay Pines, FL, USA.⁹West Palm Beach Veterans Affairs Health Care System, West Palm Beach, FL, USA

B7

Real World Experience with Use of Coagulation Factor VIIa (Recombinant)-jncw (Sevenfact) at an Academic Medical Center
Alyssa R George¹, Katelyn W Sylvester¹, Dareen M Kanaan¹, Prabashni Reddy², Jean M Connors³, Nathan T Connell³ ¹Brigham and Women's Hospital, Department of Pharmacy, Boston, MA, USA.²Mass General Brigham, Center for Drug Policy, Somerville, MA, USA.³Brigham and Women's Hospital, Division of Hematology, Boston, MA, USA

B8

Anticoagulation Stewardship in action: The experience of a Latin American center in improving adherence and reducing complications
Mayra A Arenas-Beltran^{1, 2}, Paula A Ruiz-Talero^{1, 2}, Oscar MuApoz^{1, 2}, Karen Navarro², Pilar AlarcA³n², Alice Salamanca² ¹Pontificia Universidad Javeriana, Bogota, Columbia.²Hospital Universitario San Ignacio , Bogota, Columbia

B10

Evaluation of Antithrombotic Use in Patients Presenting to the Emergency Department with a Gastrointestinal Bleed
Tara K. Lech¹, Caitlyn Leonard², Corinne M. Bertolaccini² ¹Beth Israel Lahey Health, Westwood, MA, USA.²Lahey Hospital and Medical Center, Burlington, MA, USA

B11

Assessing the Impact of an Inpatient Anticoagulation Stewardship Program
Amy Ives^{1, 2}, Harriet Kusi¹ ¹MedStar Georgetown University Hospital, Washington, DC, USA.²University of Maryland School of Pharmacy, Baltimore, MD, USA

B12

Implementation of a Clinical Surveillance Tool for Direct Oral Anticoagulation Monitoring in the Outpatient Setting
Kosha Patel¹, Alissa Nathans^{2, 3}, Drew Armstrong^{2, 3}, Jennifer Campbell^{2, 3} ¹Prisma Health Richland Hospital, Columbia, SC, USA.²Regional One Health, Memphis, TN, USA.³University of Tennessee Health Science Center, Memphis, TN, USA

B13

Evaluation of heparin nomogram performance in under- and overweight patients
Ines P. Medel, Vi Gilmore , Katie Dane, John Lindsley, Catherine Kiruthi , Michael Streiff The Johns Hopkins Hospital, Baltimore, MD, USA

B14

Pharmacy-driven Antithrombosis Stewardship consultation to promote safe, timely discharge of low-risk venous thromboembolism from the emergency department (PASS ON ADMIT Study)
Juan D Castellanos, Preeyaporn Sarangarm, Lisa Koselke, Allison E Burnett University of New Mexico Hospital, Albuquerque, NM, USA

B15

Antithrombosis Stewardship as a Key Driver Within a VTE Center Of Excellence: The AMBITION Study
Angela Martoccia Grabazs, Preeyaporn Sarangarm, Allison E Burnett University of New Mexico Hospital, Albuquerque, NM, USA

B16

The Current Landscape of Anticoagulation (AC) Stewardship Implementation Around the World: An International Survey
Nancy L. Shapiro¹, Grace A. McGee¹, Allison E. Burnett² ¹Department of Pharmacy Practice, University of Illinois at Chicago Retzky College of Pharmacy, Chicago, IL, USA.²University of New Mexico Hospital, Albuquerque, NM, USA

B17

Anticoagulation Stewardship Using a Direct Oral Anticoagulation Dashboard to Reduce Incorrect Prescribing.
Jeffrey Lee¹, Stacy Ellsworth¹, Brian Haymart², Gregory Krol¹, Bevelry Stallings¹, Noelle Ryan¹, Michael Lanham², Geoff Barnes², Scott Kaatz¹ ¹Henry Ford Health, Deroit, MI, USA.²Michigan Medicine, Ann Arbor, MI, USA

Q1

Anticoagulation Stewardship Program Impact on Deprescribing Inappropriate Antiplatelet Therapy for Patients on Oral Anticoagulation Therapy in the Outpatient Setting
Josey Poppens¹, Thaddaus Hellwig¹, Shannon Wegleitner², Sara Zochert¹, Amanda Owen², Michael Gulseth¹ ¹Sanford USD Medical Center, Sioux Falls, SD, USA.²Sanford Anticoagulation Management Services Clinic, Sioux Falls, SD, USA

Q3

Pharmacist Empowerment, Mandatory 4T Scoring and Real-time EHR Alerts to Optimize Antithrombosis Stewardship Around Diagnosis and Management of Heparin Induced Thrombocytopenia: The Persistent Study
Shruti N Karanth, PharmD, Allison Burnett, PharmD, PhC, CACP, Preeyaporn Sarangarm, PharmD, BCEMP, Chelsea Booker, PharmD, MBA, BCPS University of New Mexico, Albuquerque, NM, USA

Q4

Stewardship Role in the Periprocedural Management of Patients with Hemophilia A Before and After Introduction of Emicizumab
Daniel Cartagena-Sergenian¹, Dareen M Kanaan¹, Katelyn W Sylvester¹, Jean M Connors², Nathan T Connell² ¹Brigham and Women's Hospital, Department of Pharmacy, Boston, MA, USA.²Brigham and Women's Hospital, Division of Hematology, Boston, MA, USA

Q5

The Impact of Prospective Review of Platelet Factor 4 Testing Practices for Suspected Heparin-Induced Thrombocytopenia: An Antithrombotic Stewardship Initiative
J. Harrison Badalamenti¹, John Lindsley¹, Jessica Crow², Jessica Chasler¹, Ivo Francischetti³, Rakhi Naik⁴, Michael Streiff⁴, Jennifer Yui⁴, Katie Dane¹ ¹Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD, USA.²Department of Pharmacy, Johns Hopkins Bayview Medical Center, Baltimore, MD, USA.³ Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA.⁴Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA

ARTERIAL THROMBOSIS/PAD/ANTIPLATELET THERAPY

C1

Antiplatelet and Anticoagulant Bleeding Risk Reduction: A Collaborative Approach
Lauren Jones¹, Megan Grischeau¹, Alaa Minkara¹, Brandon Cave², Briana Ballister¹, Melissa Fontana¹, Sandra Hedin¹ ¹Centralized Anticoagulation Services Hub VA Great Lakes, Westchester, IL, USA.²West Palm Beach VA Medical Center, West Palm Beach, FL, USA

C2

Aspirin Utilization in Patients with Nonvalvular Atrial Fibrillation on Oral Anticoagulants in a Large Academic Medical Center
Morgan Quinn¹, Andrew Galascio¹, Jennifer Mazur¹, Sienna Miller¹, Joli Fermo¹, Aulbrey Drisaldi², David Cruse², Emily Ware¹ ¹Medical University of South Carolina, Charleston, SC, USA.²Pfizer Inc., New York, NY, USA

R7

Impact of Transitioning from Alteplase to Tenecteplase for Acute Ischemic Stroke
Gabriela Dominguez Arocho, Allison Bouwma, Jessica Brochu, Mathew Jones Henry Ford Health, Detroit, MI, USA

ATRIAL FIBRILLATION

D1

Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A Systematic Review and Meta-analysis
Mohamed Elshafei¹, Ahmed El-Bardissy¹, Muhammad Salem¹, Mohamed Abdelmoneim¹, Mohammed Danjuma ¹ ¹Hamad Medical Corporation, Doha, Qatar.²Hamad Medical Corporation, Doha, Qatar.³Hamad Medical Corporation, Doha, Qatar.⁴Hamad Medical Corporation, Doha, Qatar.⁵Hamad Medical Corporation, Doha, Qatar

D2

Stroke Prevention in Atrial Fibrillation and Flutter – Targeting the Untreated Patients In Veterans Health Administration with a Pharmacists-Led, Multi-Center Electronic Health Record Intervention
Arthur Allen¹, Jeffery Kibert², Geoffrey Barnes³, Michael Dyal⁴, Paul Varosy⁵, David Parra² ¹VA Salt Lake City Health Care System, Salt Lake City, UT, USA.²VISN 8 Pharmacy Benefits Management, Tampa Bay, FL, USA.³University of Michigan, Ann Arbor, MI, USA.⁴VA Miami Health Care System, Miami, FL, USA.⁵VA Eastern Colorado Health Care System, Aurora, CO, USA

D4

Antithrombotic Prescribing Practices in Patients with Atrial Fibrillation Presenting with Acute Ischemic Stroke while on Oral Anticoagulation
Corinne M. Bertolaccini¹, Collin J. Culbertson¹, Yixin Kong¹, Zhibang Lin¹, Tara K. Lech² ¹Lahey Hospital a Medical Center, Burlington, MA, USA.²Beth Israel Lahey Health, Westwood, MA, USA

D5

Impact of Amiodarone Exposure on Apixaban Pharmacokinetics in Hospitalized Patients
Samantha Kolowrat, BS, Chazmyn Riley, PharmD, Kevin Lam, PharmD, Lynda Thomson, PharmD, Douglas Stickle, PhD, Thomas Hyson, PharmD, Gil Berreby, BS, Walter Kraft, MD Thomas Jefferson University, Philadelphia, PA, USA

HEALTH DISPARITIES

E1

Impact of Food Insecurity on Anticoagulation Quality Among Patients receiving Warfarin at a Safety Net Academic Center.
Yva Gauthier², Alyssa E. Utz², Mikhail Y. Akbashev^{2, 3}, Kapil Chandora^{1, 2}, Feyi M. Ward^{1, 2} ¹Morehouse School of Medicine, Atlanta, GA, USA.²Grady Health System, Atlanta, GA, USA.³Emory University School of Medicine, Atlanta, GA, USA

E2

Social Determinants of Health Barriers within an Antithrombosis Clinic
Hannah Ayers^{1, 2}, Karen C. Thomas^{1, 2}, Lauren Wilcox^{1, 2}, Ellen Uppuluri^{1, 2} ¹University of Illinois Hospital and Health Sciences System, Chicago, IL, USA.²University of Illinois Chicago Reztky College of Pharmacy, Chicago, IL, USA

INPATIENT ANTICOAGULATION MANAGEMENT

F1

Attributable Risk of Bleeding in Pulmonary Embolism (PE): A Comparative Study of Contemporaneous Control, Symptomatic PE, and Asymptomatic PE
Sophie Samuel¹, Jamie SC Beck¹, Vi Tran² ¹Memorial Hermann Hospital, Texas Medical Center, Houston, TX, USA.²University of Texas, McGovern Medical School at UT Health, Houston, TX, USA

F2

Feel Free to Check AT3 - Baseline Antithrombin III Activity and Time to Therapeutic Anticoagulation in Mechanical Circulatory Support
Dalia Kassabieh, Benjamin August, Mathew Jones, Kristin Griebe Henry Ford Hospital, Detroit, MI, USA

F3

Evaluation of a protocol for heparin initiation in patients transitioning from Oral Factor Xa Inhibitors
Carla E. Staresinic¹, Katie L. Willenborg¹, Stephanie D. Eickman¹, Kourtney A. Peterson² ¹Madison VA Hospital, Madison, WI, USA.²Durham VA Medical Center, Durham, NC, USA

F4

The Effect of Individualized Intravenous Heparin Dosing on Activated Partial Thromboplastin Time Values in Neurocritical Care Patients
Keri S. Kim, Mya Fitzpatrick, Ruchi Patel, Nishita Gandhi, John Garofalo, Jeffrey J. Mucksavage University of Illinois Chicago Retzky College of Pharmacy, Chicago, IL, USA

F5

Derivation and Validation of a pharmacogenetic guided warfarin dosing algorithm in an Arab population residing in Qatar
Amr Fahmi¹, Ahmed El Bardissy¹, Mohamed Saad¹, Mohamed Nabil¹, Loulia Bader², Mohamed Kassem¹, Ahmed Mahfouz¹, Osama Abdelsamad¹, Abdelnasser Elzouki¹, Hazem Elewa² ¹Hamad Medical Corporation, doha, Qatar.²Qatar University, College of Pharmacy, Doha, Qatar

F6

Argatroban Use in Therapeutic Plasma Exchange (TPE): A Case of Dynamic Anticoagulation Response
Jennifer E Stanton, Alexander R Nixon Premier Health, Dayton, OH, USA

R1

Direct Oral Anticoagulants in End State Renal Disease
Avani Prabhu¹, Bhakti Singh¹, Anvi Peddi¹, Haritha Pabbathi¹, Atul Laddu¹, Jawed Fareed² ¹Global Thrombosis Forum, Suwanee, GA, USA.²Loyola University, Maywood, IL, USA

R2

History of Introduction of Direct Oral Anticoagulants and Mechanism of Action
Arya Karmarkar¹, Ashutosh Barde¹, Anterpreet Dua¹, Atul Laddu¹, Jawed Fareed² ¹Global Thrombosis Forum, Suwanee, GA, USA.²Loyola University, Maywood, IL, USA

R3

Worldwide Heparin Shortage
Maanas Deodhar¹, Surabhi Fadnavis¹, Atul Laddu¹, Jawed Fareed² ¹Global Thrombosis Forum, Suwanee, GA, USA.²Loyola University, Maywood, IL, USA

LABORATORY MONITORING

G1

Warfarin and GLP-1 Receptor Agonist Interaction Effects on Time in Therapeutic Range
Phillip Anjum^{1, 2}, Mikhail Y Akbashev^{1, 2}, Alyssa Utz², Sydney Kisala² ¹Emory University Department of Medicine, Atlanta, GA, USA.²Grady Memorial HospitalAn, Atlanta, GA, USA

G3

Making it Count: evaluating an intervention to increase usability of factor Xa inhibitor anti-Xa levels
Emily Tisler, Sara Zochert Sanford USD Medical Center, Sioux Falls, SD, USA

G4

Assessing Anticoagulation Status of a Patient with APS Using Chromogenic Factor X Testing
Katelyn N. Bell St Elizabeth Healthcare, Edgewood, KY, USA

G5

Evaluation of Heparin-Induced Thrombocytopenia Testing to Improve Anticoagulation Stewardship in an Acute Care Setting
Yelena Samofalova, PharmD¹, Nicole Thurnherr, PharmD¹, Micaela Powner, PharmD, BCPS¹, Jillian Searle, PharmD, BCPS, BCACP^{1, 2}, Michelle Byram, BS Pharm, CACP¹ ¹Saint Francis Hospital and Medical Center, Hartford, CT, USA.²Yale New Haven Health, New Haven, CT, USA

G6

Evaluation of hemoglobin monitoring frequency in patients on anticoagulation therapy
Liana Ha¹, Saira Mirza¹, Alyssa E. Utz¹, Salman Hasham¹, Mikhail Y. Akbashev^{1, 2} ¹Grady Health System, Atlanta, GA, USA.²Emory University, Atlanta, GA, USA

G7

Real-World Implementation of Latex Immunoturbidimetric Platelet Factor 4 Assay for Heparin-Induced Thrombocytopenia Diagnosis at a Large Academic Medical Center
Dareen M Kanaan¹, Gabriella C Torres², Allison L Zhang¹, Katelyn W Sylvester¹, Daniel Dees³, Elisabeth M Battinelli⁴, Jean M Connors⁴ ¹Brigham and Women's Hospital, Department of Pharmacy, Boston, MA, USA.²Brigham and Women's Faulker Hospital, Department of Pharmacy, Boston, MA, USA.³Brigham and Women's Hospital, Clinical Hematology Laboratory, Boston, MA, USA.⁴Brigham and Women's Hospital, Division of Hematology, Boston, MA, USA

G8

Clinical Performance of a Novel Point-of-Care Coagulometer, the Perosphere ClotChek™, for the DOACs
S. H. Bakhru, X. Jiang, L. Chen, D. Osmani, A. Balaj, K. Kronen, D. Mootoo, F. LaDuca, J. Ansell Perosphere, Danbury, CT, USA

PATIENT SELF-TESTING

H1

Comparison of Warfarin Time in Therapeutic Range Before and After Home Meter Enrollment
Kaitlyn P. Coggsdale, PharmD, CPP, Sarah L.E. Russell, PharmD, BCACP, CPP, Mattlyn T. Staley, PharmD, CPP, Kristin D. Bradley, PharmD, BCPS, CPP, Anne M. Rodino, PharmD, BCCP, CPP North Carolina Heart a Vascular - UNC Health Rex, Raleigh, NC, USA

H2

Impact of Home Testing on INR Control and Adverse Events in Black Patients on Warfarin for Atrial Fibrillation or Venous Thromboembolsim
Brindha Rajakumar¹, Xiaowen Kong¹, Brian Haymart¹, Scott Kaatz², Gregory Krol³, Mona Ali⁴, Noelle Ryan³, Stacy Ellsworth³, Beverly Stallings³, Tina Alexandris-Souphis¹, Amy DeLellis¹, James B. Froehlich¹, Geoffrey D. Barnes¹ ¹University of Michigan Health, Frankel Cardiovascular Center, Ann Arbor, MI, USA.²Division of Hospital Medicine, Henry Ford Hospital, Detroit, MI, USA.³Division of Internal Medicine, Henry Ford Hospital, Detroit, MI, USA.⁴Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA

H4

Point-of-Care INR Monitoring for Patients with Antiphospholipid Syndrome
Morgan T Quinn, Tara Mohit, Amy Hebbard, Rebecca Chapin, Brittany Cogdill Medical University of South Carolina, Charleston, SC, USA

PEDIATRICS

I1

Differences in Types of Thromboses and Risk Factors in Males versus Females in Adolescent Thromboembolism in the Throm-PED Registry
Lakshmi Srivaths^{1, 2}, Natalie Montanez^{1, 2}, Heleen van Ommen ³ ¹University of Texas Health Science Center at Houston, Houston, TX, USA.²Gulf States Hemophilia and Thrombophilia Center, Houston, TX, USA.³Erasmus MC Sophia Children's Hospital, Rotterdam, Netherlands

I2

Increased Neonatal Mortality and Increasing Rate of Cerebral Venous Sinus Thrombosis in Hospitalized Children: A Pediatric Health Information System Database Study
Jiasen He¹, Natalie Montanez^{1, 2, 3}, Stuart Fraser^{1, 3}, Audrey Barnett^{4, 5}, Christin Silos^{1, 3}, Keely Smith^{1, 3}, Lakshmi Srivaths^{1, 2, 3} ¹University of Texas Health Science Center at Houston, Houston, TX, USA.²Gulf States Hemophilia and Thrombophilia Center, Houston, TX, USA.³UTHealth Institute for Stroke and Cerebrovascular Disease, Houston, TX, USA.⁴Memorial Hermann Health System, Houston, TX, USA.⁵Texas EMS, Acute Care, and Trauma Foundation (TETAF), Houston, TX, USA

PERIOPERATIVE MANAGEMENT

H3J

Parenteral Bridging Practices and Outcomes in Patients on Warfarin for Mechanical Heart Valves and Venous Thromboembolism
Rachel Tang¹, Xiaowen Kong¹, Brian Haymart¹, Abigail Gredell¹, Scott Kaatz², Gregory Krol³, Mona Ali⁴, Noelle Ryan³, Stacy Ellsworth³, Beverly Stallings³, Amy DeLellis¹, James B. Froehlich¹, Geoffrey D. Barnes¹ ¹University of Michigan Health, Frankel Cardiovascular Center, Ann Arbor, MI, USA.²Division of Hospital Medicine, Henry Ford HospitalAn, Detroit, MI, USA.³Division of Internal Medicine, Henry Ford Hospital, Detroit, MI, USA.⁴Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA

J1

Comparative Analysis of Perioperative Management of Antiplatelet Agent Guidelines across US Institutions
Ming Y Lim¹, Jacob Cogan², Caroline Cromwell³, Manila Gaddh⁴, Radhika Gangaraju⁵, Colleen Morton⁶, Andrew Peseski⁷, Rishabh Singh⁸, Ishan Tatake⁹, Kimberley Youkhana¹⁰, Lisa Baumann Kreuziger¹¹ ¹University of Utah, Salt Lake City, UT, USA.²University of Minnesota, Minneapolis, MN, USA.³Icahn School of Medicine Mount Sinai, New York City, NY, USA.⁴Emory University, Atlanta, GA, USA.⁵University of Alabama at Birmingham, Birmingham, AL, USA.⁶Vanderbilt University Medical Center, Nashville, TN, USA.⁷Duke University Medical Center, Durham, NC, USA.⁸University of Illinois College of Medicine Peoria, Peoria, IL, USA.⁹Beth Israel Deaconess Medical Center, Boston, MA, USA.¹⁰Medical University of South Carolina, Charleston, SC, USA.¹¹Medical College of Wisconsin, Milwaukee, WI, USA

J2

Evaluation of a Pharmacist-led Perioperative Antithrombotic Management Service
Nghi Ha, Liza Renner, Erin Mouland, Denise Sutter-Long, Anisa Bici Michigan Medicine, Ann Arbor, MI, USA

J3

Optimizing Perioperative Anticoagulation Management: Impact of a Clinical Pharmacist Practitioner Managed Clinic on Patient Safety and Care Quality
Ruby O. Doan, April Y. Allen VA North Texas Health Care System (VANTXHCS), Dallas, TX, USA

Q6

Peri-procedural warfarin bridging evaluation for patients with atrial fibrillation enrolled in an anticoagulation management service
Hamza H Sinan¹, Katelyn W Sylvester¹, Mengyan Li¹, Ellie M Kang¹, Rebecca H Chow¹, Jean M Connors² ¹Brigham and Women's Hospital, Department of Pharmacy, Boston, MA, USA.²Brigham and Women's Hospital, Division of Hematology, Boston, MA, USA

POPULATION HEALTH

D3K

The Changing Landscape of Stroke Prevention in Subclinical Atrial Fibrillation and a Potential Path Forward in the Veteran Population: A Population Health Anticoagulation Stewardship Initiative
Arthur Allen¹, David Parra², Jeffery Kibert² ¹VA Salt Lake City Health Care System, Salt Lake City, UT, USA.²VISN 8 Pharmacy Benefits Management, Tampa Bay, FL, USA

K1

Developing an Innovative Clinical Decision Support App for Enhanced Peripheral Artery Disease Management
Kelly M. Rudd¹, Jennifer Glen², Tim Michalski² ¹Oklahoma State University Center for Health Sciences - College of Osteopathic Medicine, Tulsa, OK, USA.²EVAL Health, LLC, St. Paul, MN, USA

K2

Availability, Pricing, and Affordability of AntithromboticMedicines in Addis Ababa, Ethiopia: Implications for Health Policy
Tamrat Assefa Tadesse, Selam Birhanu, Melaku Tileku Tamiru, Hanan Muzeyin Kedir School of Pharmacy, CHS, Addis Ababa University, Addis Ababa, Ethiopia

QUALITY IMPROVEMENTS

B9L

Nonadherence to Early Discharge in Low-Risk Pulmonary Embolism: Insights from an Anticoagulation Stewardship Program in Latin America
Santiago Mendez Salazar¹, Paula Ruiz-Talero^{1, 2}, Oscar M Munoz^{1, 2}, Pilar Alarcon Robles^{1, 2}, Karen Navarro Perez^{1, 2}, Alice Salamanca^{2, 3} ¹Department of Internal Medicine, Pontificia Universidad Javeriana, BogotAi, Columbia.²Department of Internal Medicine, Hospital Universitario San Ignacio, BogotAi, Columbia.³Nursing Department Hospital Universitario San Ignacio, BogotAi, Columbia

G2L

Evolution of an Electronic Health Record-Based Alert to Optimize Venous Thromboembolism Prophylaxis
Mikhail Y Akbashev, MD, FACP1^{1, 2}, Alyssa Utz, PharmD, BCPS¹, Phillip Anjum, MD, MS^{1, 2}, Stacey M. Watkins, MD, PhD, FACP1^{1, 2}, Michael Mattaliano, PharmD¹, Palak Patel, MS, PhD¹, Debbie Vigliotti, PharmD, LSSGB¹, Mara L. Schenker, MD, MBA^{1, 3}, Bhavin B. Adhyaru MD, MS, FACP^{1, 2} ¹ Grady Memorial Hospital, Atlanta, GA, USA.²Department of Medicine, Emory University, Atlanta, GA, USA.³Department of Orthopedics, Emory University, Atlanta, GA, USA

L1

Evaluation of Current Outpatient DOAC Management Practices Within Trinity Health Grand Rapids
Ashlyn Kiebach, Kristen Eid, Daniel Boldt, Lindsey Westerhof Trinity Health Grand Rapids, Grand Rapids, MI, USA

L10

Patient Compliance with Aspirin and Rivaroxaban post Elective Joint Replacement Surgery: A Quality Assurance Initiative
Laurie A Sardo¹, Julia A Bayadinova¹, Emma K Sardo² ¹St. Joseph's Healthcare, Hamilton, Hamilton, ON, Canada.²Long Island University, Long Island, NY, USA

L2

Thrombophilia Screening in Inpatients: A Review of Testing Appropriateness and Clinical Impact in a Tertiary Hospital in Qatar
Osama Abdelsamad, Dania Alkhiyami, Syed Yameen Hasan, Eman Alhmoud, Rasha Al Anany Pharmacy Department, Al-Wakra Hospital, Hamad Medical Corporation, Doha, Qatar

L3

Rural Improvements in Venous Thrombosis Treatment in Oklahoma: The RIVETT-OK Initiative
Kelly M. Rudd¹, Jonathan Lowe¹, Bradley Anderson², Mike Shea², Jared Droze² ¹Oklahoma State University Center for Health Sciences - College of Osteopathic Medicine, Tulsa, OK, USA.²2Oklahoma State University Medicine - Virtual Care, Tulsa, OK, USA

L4

To Prescribe or Deprescribe: Antiplatelet Discontinuation versus Proton Pump Inhibitor (PPI) Addition in Veterans with Combined Antithrombotic Therapy
Laura Calderon-Lugo, Litzalee Camacho-Vega, Jennifer Crowley, Marina Babilonia-Leon Veterans Affairs Caribbean Healthcare System (VACHS), San Juan, PR, USA

L5

Heparin Management - The Ultimate Goldilocks Dilemma: a Quality Improvement Project
Malarvizhi Narayanan, Sarah Lake-Wallace, Samuel Akinyele, Teresa Allison, Julin Mathew, Megan Anderson, Latosha Mitchell, Diane Vo, Sue Thomas, Nautam Ganatra Memorial Hermann Health-System, Houston, TX, USA

L6

Improving the Anticoagulation Program Enrollment Process: A Collaboration between Unlicensed Assistive Personnel and Registered Nurses to Improve Practice and Patient Care
Kristin D.F. Negley^{1, 2}, Gina M Foster^{1, 2}, Robin Beaupre^{1, 2}, Kelly Breck^{1, 2}, Amanda Schulz^{1, 2}, Marissa Ruechel^{1, 2}, Desiree Neumann^{1, 2} ¹Mayo Clinic, Rochester, MN, USA.²Mayo Clinic Health System, Southeast, MN, USA

L8

Evaluating the Clinical Utility and Appropriateness of Four-Factor Prothrombin Complex Concentrates for Anticoagulation Reversal at an Urban, Community Academic Hospital
Nicole Thurnherr, PharmD¹, Youssef Bessada, PharmD, BCPS, BCCP² ¹Saint Francis Hospital and Medical Center, Hartford, CT, USA.²University of Connecticut School of Pharmacy, Storrs, CT, USA

L9

Evaluation of Compliance with Recommendation to Take Rivaroxaban with Food
Nghi Ha, Erin Mouland, Denise Sutter-Long, Anisa Bici, Liza Renner Michigan Medicine, Ann Arbor, MI, USA

Q7

Evaluation of Various Treatment Strategies for Acquired Hemophilia A
Agnes Musyoka, Joseph Mazur, Benjamin Djulbegovic, Jennifer Mazur, Julie Ehret, Joli Fermo, Sienna Miller Medical University of South Carolina, Charleston, SC, USA

REVERSAL OF ANTICOAGULATION

M1

Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions
Rishabh Singh¹, Ishan J Tatake², Joseph Sibley³, Radhika Gangaraju⁴, Karlyn A Martin⁵, Rachel P Rosovsky^{6, 7}, Diana Marie Byrnes⁸, Ming Y Lim⁹, Manila Gaddh¹⁰, Jacob Cogan¹¹, Kimberley Youkhana¹², Lisa Baumann Kreuziger^{3, 13}, Andrew M Peseski¹⁴ ¹University of Illinois College of Medicine Peoria, Peoria, IL, USA.²Beth Israel Deaconess Medical Center, Brookline, MA, USA.³Blood Research Institute, Versiti, Milwaukee, WI, USA.⁴University Of Alabama at Birmingham, Birmingham, AL, USA.⁵University of Vermont Larner College of Medicine, Burlington, VT, USA.⁶Massachusetts General Hospital, Boston, MA, USA.⁷Harvard Medical School, Boston, MA, USA.⁸University of Miami, Miami, FL, USA.⁹University of Utah Health, Salt Lake City, UT, USA.¹⁰Emory University School of Medicine, Atlanta, GA, USA.¹¹University of Minnesota, Minneapolis, MN, USA.¹²Medical University of South Carolina, Charleston, SC, USA.¹³Medical College of Wisconsin, Milwaukee, WI, USA.¹⁴Duke University Medical Center, Durham, NC, USA

M2

An Analysis of the Use of Andexanet Alfa at the University of Utah Hospital.
James R. Gustat, Aubrey E. Jones, Daniel M. Witt University of Utah, Salt Lake City, UT, USA

SPECIAL POPULATIONS

N2

Evaluation of Antiseizure Medication Impact on Efficacy of Direct Oral Anticoagulants
Corinne M. Bertolaccini¹, Lauren Bronson¹, Tara K. Lech² ¹Lahey Hospital a Medical Center, Burlington, MA, USA.²Beth Israel Lahey Health, Westwood, MA, USA

N3

Evaluation of Direct Oral Anticoagulant Eligibility and Prescribing for Primary Venous Thromboembolism Prevention in High-Risk Ambulatory Patients with Cancer
Michelle Wasan¹, Stefanie Houseknecht², Kelli Rourke¹, Charita Marthone³, Michael Streiff⁴, Daniel Laheru⁴, Lei Zheng⁴, Kathryn Dane¹ ¹Department of Pharmacy, The Johns Hopkins Hospital, Baltmore, MD, USA.²Department of Pharmacy, Bayview Medical Center, Baltimore, MD, USA.³Department of Pharmacy, Sibley Memorial Hospital, Baltimore, MD, USA.⁴Johns Hopkins University School of Medicine, Baltimore, MD, USA

N4

Safety and Efficacy of Direct Oral Anticoagulants in Patients with Body Mass Index ≥40 kg/m2
Anisa Bici, Denise Sutter-Long, Liza Renner, Erin Mouland, Nghi Ha Michigan Medicine, Ann Arbor, MI, USA

N5

Safety and Efficacy of Apixaban in Patients Receiving Hemodialysis Compared to Patients with Moderate Renal Dysfunction
Denise Sutter-Long, Anisa Bici, Erin Mouland, Liza Renner, Nghi Ha Michigan Medicine, Ann Arbor, MI, USA

N6

Safety and Efficacy of the Use of Direct Oral Anticoagulants in Patients with a History of Bariatric Surgery
Nicholas Shabanowitz, Kayla Popova, Michelle Schultz, Nghi Ha Michigan Medicine, Ann Arbor, MI, USA

N7

Fat-Specific S6 Kinase Gene Inhibition: A Novel Strategy to Improve Metabolic Health and Anticoagulation Outcomes in Diabetes-Associated Thrombosis
Siddarth Suresh Innovation Academy, Alpharetta, GA, USA

R4

Women in Science
Isha Jayakumar¹, Nila Jayakumar¹, Srishti Sawant¹, Gitika Aggarwal¹, Atul Laddu¹, Jawed Fareed² ¹Global Thrombosis Forum, Suwanee, GA, USA.²Loyola University, Maywood, IL, USA

R5

The Youth is our Future, and the Future is Here
Omkar Garud¹, Naga Sahithi Rajuladevi¹, Sonika Tatipalli¹, Atul Laddu¹, Jawed Fareed² ¹Global Thrombosis Forum, Suwanee, GA, USA.²Loyola University, Maywood, IL, USA

TRANSITIONS OF CARE

O1

Deficits in Warfarin Discharge Planning: Improving Transitions of Care for Patients on Warfarin at a Community Teaching Hospital
Krista Luck, Amira Carter, Sesalie Rhinehart, Elizabeth Ramsaur, Christie Dresback Mission Hospital, Asheville, NC, USA

O2

Patient-Education Video Development and Implementation
Audrey Socha^{1, 2}, Brian Schlitt^{1, 2}, Stephanie Neilson¹, Deborah Gillard¹, Janelle Juul¹, Courtney Wack¹, Aaron Glueckstein¹, Ceanne Simmelink¹, Susan Hahn¹, Alyssa Schaller¹ ¹Froedtert Health, Milwaukee, WI, USA.²Froedtert Menomonee Falls Hospital, Menomonee Falls, WI, USA

Q8

Creation of Patient Self-Managed Warfarin Program Within an Anticoagulation Clinic
Julia Kluck¹, Jennifer Hardman¹, Lisa Baumann Kreuziger^{1, 2}, Hannah Breidenbach¹, Eric Mendez-Michler¹, Michelle Te Ronde¹, Jesse Kutz¹, Rebecca Wong¹ ¹Froedtert a the Medical College of Wisconsin, Milwaukee, WI, USA.²Medical College of Wisconsin Division of Hematology and Oncology, Milwaukee, WI, USA.³Versiti Blood Center of Wisconsin, Milwaukee, WI, USA

VENOUS THROMBOEMBOLISM

P1

Analysis of Xa levels and PTTs during the first 48 hours of anticoagulation with unfractionated heparin infusion
Kaitlyn Loi Community Regional Medical Center, Fresno, CA, USA

Q2

Evaluating the Effectiveness and Tolerability of UFH vs. LMWH for VTE Prevention in Underweight Patients: A retrospective cohort study
Mohammad T Alashqar¹, Pardis Niami¹, Adam Cuker² ¹Hospital of the University of Pennsylvania, Department of Pharmacy Services, Philadelphia, PA, USA.²Hospital of the University of Pennsylvania, Department of Medicine and Department of Pathology a Laboratory Medicine, Philadelphia, PA, USA

R6

Elevation of D-Dimer Without Any Evidence of Venous Thromboembolism: What Is Your interpretation?
Om Joshi¹, Riddhi Surve¹, Deepa Nagarajan¹, Atul Laddu¹, Jawed Fareed² ¹Global Thrombosis Forum, Suwanee, GA, USA.²Loyola University, Maywood, IL, USA